Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy.

Jang, Soo Min; Yessayan, Lenar; Dean, Michael; Costello, Gabrielle; Katwaru, Ravi; Mueller, Bruce A

Jang, Soo Min; Yessayan, Lenar; Dean, Michael; Costello, Gabrielle; Katwaru, Ravi; Mueller, Bruce A.

Afiliação

Jang SM; Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, CA 92350, USA.
Yessayan L; Department of Medicine Division of Nephrology, Michigan Medicine, Ann Arbor, MI 48109, USA.
Dean M; Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL 60515, USA.
Costello G; College of Human Medicine, Michigan State University, East Lansing, MI 49503, USA.
Katwaru R; Merck & Co., Kenilworth, NJ 07033, USA.
Mueller BA; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI 48109, USA.

Antibiotics (Basel) ; 10(10)2021 Sep 29.

Article em En | MEDLINE | ID: mdl-34680765

Palavras-chave

CRRT; clearance; imipenem; pharmacokinetics; relebactam

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Antibiotics (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google